CClinicalTrials.gg
CompletedNCT02166164Updated Jan 27, 2015

Characterization of Secondary Hyperalgesia in Healthy Volunteers

An interventional study of Brief thermal sensitization and Long thermal stimulation in Experimental Pain in Healthy Males, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-01-27.

Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 35 Years
Sex
Male
01

Study summary

In this prospective trial we aim to investigate the intra-individual and inter-individual variance in secondary hyperalgesia following pain elicited by the experimental pain model: Brief Thermal Sensitization.

Furthermore we wish to investigate how precise the psychological tests, Pain Catastrophizing Scale and Hospital Anxiety and Depression Scale predict the size of the area of secondary hyperalgesia.

02

Conditions studied

  • Experimental Pain in Healthy Males

Browse trials for

Keywords

  • Pain
  • Secondary hyperalgesia
  • thermal sensitization
  • Catastrophization
  • Anxiety
03

In context

Hyperalgesia

152 studies on the registry are indexed under Hyperalgesia; 13 are open to participants now.

This study's planned enrollment of 50 is above the median of 42 across 127 interventional studies indexed under Hyperalgesia.

Browse Hyperalgesia studies →

Lead sponsor

Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age >18 years and \<35 years
  • Speak and understand Danish
  • Male gender
  • Test subjects who have understood and signed the informed consent
  • No prescription medicine during the last 30 days

Exclusion criteria

Exclusion Criteria:

  • Test subjects that cannot cooperate to the test
  • Test subjects with an alcohol and/or substance abuse, assessed by the investigator
  • Test subjects, who have consumed one or several types of analgesics 2 \<days before the study
  • Test subjects, who have consumed antidepressant medication during the last 30 days before the study
  • Test subjects with chronic pain
  • Test subjects with psychiatric diagnoses
  • Test subjects with tattoos on the extremities
  • Body Mass Index of >30 or \<18
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Experiemental pain models

    all study participants will be tested with the same experimental pain models: Brief thermal sensitization, Long thermal stimulation, and Heat-pain-detection threshold.

    Other: Brief thermal sensitization · Other: Long thermal stimulation · Other: Heat-pain-detection threshold

Interventions

  • OtherBrief thermal sensitization

    A small area of the skin of the study participants are heated to 45 degree celsius for 3 minutes, followed by evaluation of secondary hyperalgesia.

    Also known as: Experimental thermal pain model

  • OtherLong thermal stimulation

    A small area of the skin of the study participants are heated to 45 degrees celsius for 1 minute. During the 1 minute period, the study participant will continually report pain on an electronic visual analog scale.

    Also known as: Experimental pain model

  • OtherHeat-pain-detection threshold

    The threshold for heat pain are evaluated by heating a small area of the study participants skin. When the study participant feels pain, the temperature (degrees celsius) is registered. 4 threshold measurements per session. Heat pain threshold is defined as the average temperature of the 4 measurements.

    Also known as: Experimental pain model

06

What researchers measure

Primary outcomes

  1. Change in area of secondary hyperalgesia following brief thermal sensitization

    To determine the intra- and inter-individual variance, and the inter- and intra-observer variance of the secondary hyperalgesia areas following brief thermal sensitization on 4 separate experimental days with two different observers.

    Time frame: Study day 1, 2, 3, and 4. A minimum of 4 weeks.

Secondary outcomes

  1. Score of Pain Catastrophizing Scale

    How precise does the score of the Pain Catastrophizing Scale predict the size of the area of secondary hyperalgesia?

    Time frame: 7 days

  2. Score of Hospital Anxiety and Depression Scale

    How precise does the score of the Hospital Anxiety and Depression Scale predict the size of the area of secondary hyperalgesia?

    Time frame: 7 days

  3. Score of Subscales of Pain Catastrophizing Scale and Hospital Anxiety and Depression Scale

    How precise do the subscales in the two psychological tests (PCS-rumination, PCS-magnification, PCS-helplessness, and HADS-Anxiety, HADS-Depression) predict the size of the area of secondary hyperalgesia?

    Time frame: 7 days

  4. Heat-pain-detection threshold registered by degrees celsius

    How precise do the Heat-pain-detection threshold evaluated on the 4 experimental days predict the size of the area of secondary hyperalgesia on the respective 4 experimental days? 4 sessions of Heat-pain-detection threshold on 4 separate experimental days with 1 session per experimental day.

    Time frame: 1 minute per session

  5. Pain following Long Thermal Stimulation, evaluated by maximum on the visual analog scale

    How precise does the Max. VAS-score following Long Thermal Stimulation evaluated on the 4 experimental days predict the size of the area of secondary hyperalgesia on the respective 4 experimental days? 4 sessions of Long Thermal Stimulation on 4 separate experimental days with 1 session per experimental day.

    Time frame: 1 minute per session

  6. Pain following Long Thermal Stimulation, evaluated by Area under the curve of the visual analog scale.

    How precise does the VAS-Area Under the Curve following Long Thermal Stimulation evaluated on the 4 experimental days predict the size of the area of secondary hyperalgesia on the respective 4 experimental days? 4 sessions of Long Thermal Stimulation on 4 separate experimental days with 1 session per study day.

    Time frame: 1 minute per session

07

Study locations

1 site
  • Department of anaesthesia and surgery, 4231, Rigshospitalet
    Copenhagen, 2100, Denmark
08

References and documents

Publications

  • Hansen MS, Wetterslev J, Pipper CB, Ostervig R, Asghar MS, Dahl JB. The Area of Secondary Hyperalgesia following Heat Stimulation in Healthy Male Volunteers: Inter- and Intra-Individual Variance and Reproducibility. PLoS One. 2016 May 11;11(5):e0155284. doi: 10.1371/journal.pone.0155284. eCollection 2016. Erratum In: PLoS One. 2017 Apr 13;12(4):e0176081. doi: 10.1371/journal.pone.0176081. PubMed 27167119 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02166164
Lead sponsor
Rigshospitalet, Denmark
Collaborators
Copenhagen Trial Unit, Center for Clinical Intervention Research, University of Copenhagen
Responsible party
Morten Sejer Hansen (MD, Rigshospitalet, Denmark) — Principal investigator
First posted
Jun 18, 2014
Start date
Jun 2014
Primary completion
Jan 2015
Completion
Jan 2015
Last update
Jan 27, 2015

Study contacts

Jørgen B Dahl, MD, Doc. Med, Consultant
study director · Department of anaesthesiology, dep. Z, Bispebjerg Hospital, Denmark

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion